Arena Pharmaceuticals Inc. (ARNA): ARNA moving up?


Arena Pharmaceuticals Inc. (NASDAQ:ARNA) changes shares on Tuesday trading session, with a change of 0.39% or $0.25 shares. The trading starts at $63.02 and closed at $63.36 throughout the day. The trading session low price was $62.26 and day high was $64.155 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.53 million while its average volume is 776.55K. In other hand, the ARNA market cap reached to $3.64B. While, its current target price is $79.08.

On June 16, 2020, BRIEF-Arena Pharmaceuticals Says Board Increased Size Of Board To 9 Directors – SEC Filing. According to the news reported on Reuters, * ARENA PHARMACEUTICALS SAYS BOARD INCREASED SIZE OF BOARD FROM 8 DIRECTORS TO 9 DIRECTORS – SEC FILING Source text: Further company coverage:

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 2.61% and up 0.16% for month. Its quarterly performance was 25.76% above, while its half year performance is up 30.59%. ARNA yearly performance stood at positive 5.81% and rise 40.05% for year-to-date. Current recommendation for Arena Pharmaceuticals Inc. is 1.60.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. ARNA EPS (TTM) for 12-month is -6.46. EPS for this year is -210.10%, while for the next year its value is -8.34. Its EPS Q/Q reached -116.50%. It has an EPS of 36.80% up for past five years.

Let’s take a look on the analyst recommendations on ARNA for the current month and previous month. For the current month, 12 of 12 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 10 analysts participate in stock recommendation. Out of 10, 0 rated it sell, 10 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $60.00 – $95.00. Average target price for ARNA was reached at $78.50.

The insider ownership moved to 0.20% and institutional holding shifted to 80.70%.

The company posted an EPS (TTM) of -6.46. According to the most recent quarter report on (Jun 2020), 12 analysts estimated an average EPS of -2.03, while -1.24 EPS posted a year ago period. Analyst Estimated EPS for ARNA published in the report was -$2.21 – -$1.81 during the same period. Comparing with last year, the average estimated EPS was -1.24 which is higher than -2 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for ARNA rise 24.00% for period of 200 days. SMA for 50 days was -0.01% which is showing red signal, while SMA-20 was -1.57%. The moving average value for Arena Pharmaceuticals Inc. (ARNA) is 3.91M and 7.32% for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in ARNA stock. On Jul 15, Cabell Christopher, EVP, Head of R&D, and CMO, sold 13,000 trading shares at the cost of $68.00, which valued at 0.88 million. On Jun 17, Soni Manmeet Singh, Director, sold 304 shares at the cost of $62.74, with total shares of 5,902. On Jun 15, Soni Manmeet Singh, Director, sold 1,327 shares at the cost of 60.12. After this transaction, Soni Manmeet Singh total shares reached to 6,206 which valued at 79779.0.